Brief: IPA Reports Q3 Financial Results

Mindwalk Holdings

16/03/2023 12:38

March 16 (Reuters) - Immunoprecise Antibodies Ltd
 IPA.O :
    * IPA REPORTS FINANCIAL RESULTS AND RECENT BUSINESS
HIGHLIGHTS FOR
THIRD QUARTER FISCAL YEAR 2023
    * IMMUNOPRECISE ANTIBODIES - IPA ACHIEVED REVENUE OF $5.2
MILLION
DURING THREE MONTHS ENDED JANUARY 31, 2023, A 7.4% INCREASE
    * IMMUNOPRECISE ANTIBODIES - DOES NOT HOLD CASH AT SILICON
VALLEY
BANK AND HAS NOT SEEN ANY IMPACT ON CO'S BUSINESS FROM COLLAPSE
    * IMMUNOPRECISE ANTIBODIES LTD - QTRLY GROSS PROFIT
INCREASED
14.6% TO $3.0 MILLION

Source text for Eikon:  ID:nBw6hvKhba 
Further company coverage:  IPA.O 

 ((Reuters.Briefs@thomsonreuters.com;))